REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Milpharm, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Full name: Milpharm, S.R.O. Profile Updated: July 20, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Milpharm, S.R.O. is an enterprise in Slovakia, with the main office in Brezno. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on December 23, 2005. 5 - 9 (2025) employees currently work for Milpharm, S.R.O.. In 2024, the company reported a net sales revenue drop of 5.07%. Over the same period, its total assets grew by 8.78%. The net profit margin of Milpharm, S.R.O. decreased by 0.08% in 2024.

Headquarters
Ceskoslovenskej Armady, 72/62
Brezno; Banskobystricky; Postal Code: 97701

Contact Details: Purchase the Milpharm, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Milpharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Milpharm, S.R.O. report to view the information.
Financial Auditors:
Purchase the Milpharm, S.R.O. report to view the information.
Incorporation Date:
December 23, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Milpharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.07%▼
Total operating revenue
-5.07%▼
Operating profit (EBIT)
-8.17%▼
EBITDA
-5.83%▼
Net Profit (Loss) for the Period
-6.84%▼
Total assets
8.78%▲
Total equity
11.15%▲
Operating Profit Margin (ROS)
-0.16%▼
Net Profit Margin
-0.08%▼
Return on Equity (ROE)
-1.91%▼
Debt to Equity Ratio
0.05%▲
Quick Ratio
4.58%▲
Cash Ratio
4.16%▲

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Dr.Max 138 T, S.R.O.
 
W + W, Spol. S R.O.
Zdenpharm, S.R.O.
 
Dr.Max 95 S.R.O.
Bardfarm, S. R. O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo